Graham Belgrave is Senior Vice President, Head of Global Medical and Regulatory Affairs and Managing Director Europe at Advanced Clinical. He has over 39 years of experience successf
The pharmaceutical industry has sometimes been a laggard in terms of digital maturity, but the COVID-19 crisis has provided companies the impetus to rapidly implement the most cutting-edge
Bristol-Myers Squibb’s hopes of adding a new indication to the label for S1P modulator Zeposia have been dented after the drug failed a phase 3 trial in Crohn’s disease.